Actuate Therapeutics, Inc.

Actuate Therapeutics, Inc. financial statements

Actuate Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 22.23M10-K
Cash and equivalentsUSD 13.16M10-K
Total debtUSD 404.99KEODHD

Actuate Therapeutics, Inc. financials on 6ix · Actuate Therapeutics, Inc. on 6ix